Are you a healthcare professional? To access professional information, please visit the ZResource Hub.

Hello

This website contains information about medicines supplied by Zambon in the UK. These medicines are only available on prescription and this website is not intended to replace the advice of a healthcare professional.

You can use this website to find:

Information about diseases and treatments

General information about Zambon medicines

Information for patients who have been prescribed Zambon medicines

You should consult your doctor or another suitably trained healthcare professional when considering what type of treatment is most appropriate for you or if you have any questions about medicines prescribed to you.

Want to know more about Zambon in the UK?

Please visit the link below:

Zambon in the UK

Therapy areas

Parkinson's Disease

Parkinson’s disease is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement.

Cystic Fibrosis

Cystic fibrosis is an inherited condition that causes sticky mucus to build up in the lungs and digestive system. This causes lung infections and problems with digesting food. In the UK, most cases of cystic fibrosis are picked up at birth using the newborn screening heel prick test.

Antibiotics

Antibiotics are used to treat or prevent some types of bacterial infection. They work by killing bacteria or preventing them from reproducing and spreading. But they don’t work for everything. Antibiotics don’t work for viral infections such as colds and flu, and most coughs and sore throats.

Medicines

Xadago (safinamide) 50mg and 100mg film-coated tablets

Patient Information Leaflet

Summary of Product Characteristics

European Public Assessment Report

Promixin (colistimethate sodium) 1 million international units (IU) powder for nebuliser solution

Patient Information Leaflet

Summary of Product Characteristics

European Public Assessment Report

Monuril (fosfomycin) 3g granules for oral solution

Patient Information Leaflet

Summary of Product Characteristics

European Public Assessment Report

GB_COM_338

August 2022

Adverse event reporting

Yellow card

Adverse reactions should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse reactions should also be reported to Zambon UK at drugsafetyUK@ZambonGroup.com or telephone: +44 (0) 800 0288 942

Adverse event reporting